News

STAT12d
Appeals court reopens the question of who owns patents for groundbreaking CRISPR discovery
A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...
Nobel Prize winners convince court to revive CRISPR patent dispute
The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...
Federal Circuit CRISPR Patent Remand Ignites ‘Conception’ Debate
A favorable appeals court ruling repositioned a coalition of universities and Nobel laureates to win credit for inventing a ...
Nature6d
World first: ultra-powerful CRISPR treatment trialled in a person
The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...
pharmaphorum5d
China to begin first in-human CRISPR trial next month
The CRISPR-led gene-editing revolution is set to begin next month in its first ever trial in humans ... than current PD-1–targeted drugs as the technology directly knocks-out the gene ...
UC San Francisco6mon
Novel Gene Therapy Trial for Sickle Cell Disease Launches
The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease. Sickle cell disease is a genetic ...
News Medical6mon
First U.S. trial uses non-viral CRISPR to correct sickle cell mutation
The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease. The research involves taking ...